Very long-chain polyunsaturated fatty acids incorporation into cellular lipids and membranes

Very long-chain polyunsaturated fatty acids (VLC-PUFAs) incorporation into cellular lipids and membranes is a specialized metabolic process essential for maintaining the structural and functional integrity of highly fluid biological membranes. This pathway involves the elongation of long-chain polyunsaturated fatty acids, typically 20-22 carbons in length, into species containing 24 to 38 carbons, a reaction primarily catalyzed by the enzyme ELOVL4 (Agbaga et al., 2010, PNAS). Once synthesized, these VLC-PUFAs are incorporated into phospholipids and are highly concentrated in specific tissues such as the retina, brain, and testes, where they support critical functions like visual phototransduction and synaptic plasticity (Jump, 2009, JBC). Disruptions in this incorporation process, often due to genetic mutations in the ELOVL4 or FADS enzymes, are associated with severe pathologies including juvenile macular degeneration (Stargardt disease 3) and spinocerebellar ataxia (UniProt Q9GZR5). While the process itself is not a single molecular target, it is a focal point for therapeutic intervention through dietary supplementation with omega-3 precursors or experimental gene therapies designed to restore enzymatic activity within the pathway. Understanding the regulation of VLC-PUFA incorporation is vital for developing treatments for neurodegenerative and retinal disorders where membrane lipid composition is compromised.

Other names

VLC-PUFA biosynthesisVLC-PUFA metabolismVery long-chain fatty acid elongation pathwayMembrane VLC-PUFA enrichment

Substrate supplementation to provide precursors for enzymatic elongation by ELOVL4 and subsequent incorporation into complex lipids like phosphatidylcholine.